Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1743.19 | 6235.00 | 6349.75 | 0.9819 | 0.9805 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 5000.00 | 1743.19 | 4199.00 | 6349.75 | 0.6613 | 0.6022 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1743.19 | 6231.00 | 6349.75 | 0.9813 | 0.9799 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 5000.00 | 1743.19 | 4034.00 | 6349.75 | 0.6353 | 0.5682 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6497.00 | 6349.75 | 1.0232 | 1.0247 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6159.00 | 6349.75 | 0.9700 | 0.9676 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 5000.00 | 1743.19 | 6253.00 | 6349.75 | 0.9848 | 0.9836 |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6293.00 | 6349.75 | 0.9911 | 0.9904 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6019.00 | 6349.75 | 0.9479 | 0.9435 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6104.00 | 6349.75 | 0.9613 | 0.9581 | |
| SK-BR-3 | 0 | uM | 8 | 5000.00 | 1743.19 | 6018.00 | 6349.75 | 0.9478 | 0.9433 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5998.00 | 6349.75 | 0.9446 | 0.9398 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 5000.00 | 1743.19 | 5901.00 | 6349.75 | 0.9293 | 0.9229 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 3418.00 | 6349.75 | 0.5383 | 0.4348 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 5000.00 | 1743.19 | 4871.00 | 6349.75 | 0.7671 | 0.7350 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 6127.00 | 6349.75 | 0.9649 | 0.9621 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6304.00 | 6349.75 | 0.9928 | 0.9923 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5936.00 | 6349.75 | 0.9348 | 0.9290 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 4296.00 | 6349.75 | 0.6766 | 0.6220 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 5000.00 | 1743.19 | 4057.00 | 6349.75 | 0.6389 | 0.5729 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6369.00 | 6349.75 | 1.0030 | 1.0032 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1743.19 | 6325.00 | 6349.75 | 0.9961 | 0.9958 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 5000.00 | 1743.19 | 6215.00 | 6349.75 | 0.9788 | 0.9771 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5036.00 | 6349.75 | 0.7931 | 0.7662 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 4818.00 | 6349.75 | 0.7588 | 0.7248 |